← Back to Search

Stretching Exercises for Pregnancy and Obesity

N/A

Waitlist Available

Led By SeonAe Yeo, PhD, FAAN

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 37 gestational weeks

Awards & highlights

Study Summary

This trial will compare the effects of a stretching intervention versus moderate/vigorous activity on pregnant women.

Who is the study for?

This trial is for pregnant women with obesity, carrying one baby and less than 24 weeks into their pregnancy. They should have a BMI of 30 or higher at their first prenatal visit and must speak English or Spanish. It's not for those who plan to give birth before 37 weeks, move away during the study, or can't exercise regularly.Check my eligibility

What is being tested?

The trial is testing if stretching exercises are better than the usual care (moderate to vigorous activity for 30 minutes daily, five days a week) in reducing cardiovascular risks in obese pregnant women between their 27th and 37th gestational weeks.See study design

What are the potential side effects?

Stretching exercises are generally safe but may include muscle soreness or strain. The risk of serious side effects is low compared to more strenuous activities, especially when tailored for late-stage pregnancy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 37 gestational weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 37 gestational weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 37 gestational weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in arterial stiffness assessed by SphygmoCor XCEL from baseline (27 gestational weeks) to 32 gestational weeks

Change in arterial stiffness assessed by SphygmoCor XCEL from baseline (27 gestational weeks) to 37 gestational weeks

Change in diastolic blood pressure from baseline (27 gestational weeks) to 32 gestational weeks

+7 more

Secondary outcome measures

Child being large for gestational age at the end of pregnancy

Child being small for gestational age at the end of pregnancy

Composite Score of Fetal/Neonatal Outcomes at the End of Pregnancy.

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Prenatal Heart Smart InterventionExperimental Treatment1 Intervention

This group will have usual care completed and supportive calls from a facilitator to discuss adherence to the home exercise. In addition, the group will complete a sequential static stretching exercise 5 days per week for 10 weeks. The stretching exercise consists of 20 seconds of stretching, for 3 repetitions per muscle group.

Group II: Usual Care (Control)Active Control1 Intervention

This group will have usual care completed and supportive calls from a facilitator to discuss adherence to the home exercise. In addition, this group will complete moderate-intensity walking 5 days per week for 10 weeks in accordance to usual care.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Stretching Exercise Intervention

2013

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor

1,504 Previous Clinical Trials

4,187,356 Total Patients Enrolled

64 Trials studying Obesity

57,748 Patients Enrolled for Obesity

National Institute of Nursing Research (NINR)NIH

579 Previous Clinical Trials

10,376,076 Total Patients Enrolled

16 Trials studying Obesity

3,156 Patients Enrolled for Obesity

SeonAe Yeo, PhD, FAANPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Media Library

Stretching Exercise Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04291560 — N/A

Obesity Research Study Groups: Usual Care (Control), Prenatal Heart Smart Intervention

Obesity Clinical Trial 2023: Stretching Exercise Intervention Highlights & Side Effects. Trial Name: NCT04291560 — N/A

Stretching Exercise Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04291560 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the goals of this experiment?

"The primary objective of this clinical trial, which spans from Baseline to 37 gestational weeks is an appraisal of the Change in high frequency heart rate variability from its initial measure at 27 gestational weeks. Secondary objectives include detecting Onset of preeclampsia anytime between baseline (27 weeks gestation) and the end of pregnancy, Intrauterine death at end of pregnancy, as well as measuring for Onset of Pregnancy Induced Hypertension anytime between baseline (27 Weeks Gestation) and the end of pregnancy."

Answered by AI

Is enrollment still open to participate in this trial?

"According to clinicaltrials.gov, this medical trial is currently not recruiting participants as the last update was on November 3rd 2022. Despite its inactivity, there are over one thousand different trials around the world that are presently seeking patients for their studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity

2020. "Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04291560.

All > Cardiovascular